Expect an evening of dynamic speakers, strategic deep dives, and industry insights from our expert lineup. Please find speaker bios below. The event will focus on the challenges and opportunities of this exciting next step in healthcare. We will also be joined by Venture Lab NGK SPARK PLUG, CO., LTD. portfolio company partners who will share the latest developments and product demonstrations of their groundbreaking technology.

Read on eventbrite.com

The strengths and challenges to providing MOUD in each community and clinic vary. This session will discuss the role that telemedicine can play in expanding access to MOUD in rural communities. Telemedicine can be provided by rural clinics themselves, or by external telemedicine providers to whom a rural clinic refers some or all of its patients with OUD. Through case examples, the presenters will highlight how telemedicine has been used to improve access to initiating and maintaining MOUD in rural communities, and share experiences using telemedicine approaches. 

Read on uclahs.zoom.us

This event connects you with public and private payers for direct perspective into policy development and decision-making frameworks so you can successfully expand product coverage. Avoid pitfalls and improve market access through lessons learned, and collaborate on solutions during Q&A after peer-led case studies and success stories. Develop relationships with decision-makers as well as diagnostic industry peers in interactive discussion-based sessions. Through dynamic presentations from these commercial payer organizations as well as laboratories, test manufacturers, law firms and solution providers, learn in an intimate environment. Retain expert insights and address your individual questions on policy and coverage decisions so you can perfect your strategy to optimize reimbursement.

Read on q1productions.com

N-Nitrosamine impurity findings in marketed formulations of rifampin have disrupted drug development. As a strong cytochrome P450 3A4 (CYP3A4) inducer, rifampin was regularly co-administered with investigational products during pharmacokinetic drug-drug interaction studies. However, due to recent impurity issues, its application in these studies has been suspended in both the US and EU. This webinar will examine the root cause of rifampin impurity and describe the industry and regulatory response to this issue. In addition, the featured speakers will address alternative approaches and CYP3A inducers to encourage the continuation of drug-drug interaction studies and drug development.

N-Nitrosamines are a class of chemicals recognized as a “cohort of concern” due to their mutagenic and carcinogenic potential. Typically, levels above an acceptable intake limit may lead to a probable or possible risk of cancer in humans. Rifampin capsules were found to contain 1-methyl-4-nitrosopiperazine (MNP) above the acceptable intake limit of 0.16 ppm. However, it’s important to note that nitrosamines are not limited to drug products, and low levels can be found in drinking water, processed meats and tobacco exposure. Therefore, in theory, a diet low in nitrosamines could offset any potential exposure during rifampin drug-drug interaction studies.

Read on xtalks.com

This course is aimed at residents in their 4th and 5th year of training in radiology and recently board-certified radiologists interested in Musculoskeletal Radiology. It is strictly adhered to Level II of the European Training Curriculum. The course includes six topics consisting of 40 minutes of theory and case presentations followed by a live Q&A section after each session for interaction with the faculty members.

Read on connect.myesr.org

The medical technology industry becomes an essentiel component of the whole care pathway. Advanced technologies such as Smart connectivity, Health Sensors, AI/ML in decision making, robotics, VR/AR/XR are not only improving medical devices but also are opening new perspectives for the care of human beings. According to « Absolute Markets Insights ». Global medical technology market was valued at US$ 565,52 billion in 2018 and is expected to reach 2324.34 billion by 2027, growing at an estimated CAGR of 17.1% over the forecast period. The segments that we will develop in this conference are about the use of solutions in the field of of mHealth, eHealth, telemedicine, telematics / telemetry, medical information systems / software, Medical Apps, portable diagnostics, wearables and augmenting human features and well beings.

Read on net-must.com

We are delighted to announce “International Conference on Ophthalmology & Vision Research” which is scheduled to be held during December 7-8, 2022, Dubai, UAE to share your views and thoughts about various aspects in Ophthalmology. The theme of our conference is “Recent Innovations In Ophthalmology For The Treatment Of Eye Disorders” which further explains about the recent trends and advancements that are taking place in the field of Vision Science along with the related topics such as Ophthalmology Disorders, Major Ophthalmologic Surgeries, Eye Care and Advancements, Cataracts, Glaucoma, Novel Advances in Vision Improvement etc. explained by experts and young researchers in respective backgrounds through their presentations on various sessions in this Conference.

Read on meetingsint.com

LUMIMINDS CONVENTIONS is glad to announce our upcoming International Conference on Oncology and Radiology – ICOR 2022 that will be held Online during December 07-08, 2022. The theme of the conference is “Upcoming technologies that revolutionize the future of cancer treatment”. We take great pleasure in inviting all the Academicians, Scientists, Young Researchers and Students, Oncologists, Radiologists, Cancer therapists, Radiation Oncologists, Clinical Professionals, and Business professionals pertaining to across the world for our upcoming ICOR 2022 to witness and participate in highly professional scientific discussions and sessions. ICOR 2022 will have Invited Talks/Keynote Talks, Scientific Sessions, Workshops, Poster Presentations, Networking Sessions, etc. As part of encouraging young researchers, we have a special session, the Young Scientist Session. Hope you all join and make the most exciting event of the year successful. You are assured of discovering the latest developments and breakthroughs that are exclusive to your field of work with its scientific sessions.

Read on lumiminds.org

The Franchise Forum returns this year to bring together leaders in the home-based care franchising field to discuss the emerging trends and pressing challenges in home health and home care. This complimentary webinar series will feature a Home Care Franchise outlook panel and a round table of select franchise owners. In addition, the event will also include two, 30-minute sessions for industry participants to connect to HHCN’s audience.

Read on franchiseforum.homehealthcarenews.com

The Healthcare Finance and Revenue Cycle Management Forum has a delicate balance of revenue cycle executives coupled with finance executives in order to create a blend of presentations that are intriguing and relevant to the healthcare industry in its current and evolving states. From physicians, payers, and up to financial executives, there is a need and desire to come together to provide the best care for the most important link in the chain: the patient. With extensive research and knowledge gathering from past events, Q1 Productions has crafted each session topic with accomplished speakers in order to deliver an exemplary and knowledgeable forum experience to our attendees.

Read on q1healthcareforums.com